| 5-HT2R | 5-hydroxytryptamine receptor 2A |
| Acetyl-CoA | Acetyl coenzim A |
| ADH | Alcohol dehydrogenase |
| AhR | Aryl hydrocarbon receptor |
| ALDH | Aldehyde dehydrogenase |
| AP1 | Activator protein 1 |
| AUD | Alcohol use disorder |
| AUDIT | Alcohol use disorders identification test |
| CAGE | Cutting down, Annoyance by criticism, Guilty feeling, and Eye-openers |
| CCL20 | C-C Motif chemokine ligand 20 |
| CDT | Carbohydrate-deficient transferrin |
| c-Jun | Proto-oncogene c-Jun |
| CNS | Central nervous system |
| CYP2E1 DA |
Cytochrome P450 isoform 2E1 Dopamine |
| DLQI | Dermatological life quality index |
| GABRA2 | Gamma-aminobutyric acid type A receptor subunit alpha2 |
| GABRG1 | Gamma-aminobutyric acid type A receptor subunit gamma1 |
| HPA-axis | Hypothalamic–pituitary–adrenal axis |
| IFNγ | Interferon-γ |
| IL | Interleukin |
| JAK | Janus kinase |
| KGFR | Keratinocyte growth factor receptor |
| MAPK | Mitogen-activated protein kinase |
| NAD | Nicotinamide adenine dinucleotide |
| NAFLD | Non-alcoholic fatty liver disease |
| NF-κB | Nuclear factor kappa-B |
| NLRP3 | NLR family pyrin domain containing 3 |
| OPRM1 | μ-opioid receptor 1 |
| PASI | Psoriasis Area Severity Index |
| PBMC | Peripheral blood mononuclear cell |
| Peth | Phosphatidylethanol |
| PKC | Protein kinase C |
| RALDH | Retinaldehyde dehydrogenase |
| RDH ROS |
Retinol dehydrogenase Reactive oxygen species |
| SNP | Single nucleotide polymorphism |
| SSRI | Selective serotonin reuptake inhibitor |
| STAT | Signal transducers and activators of transcription |
| sTNF-R1 | Soluble TNF-receptor 1 |
| TACE | TNFα-converting enzyme |
| TGFα | Transforming growth factor-α |
| Th | T-helper |
| TNFR | Tumor necrosis factor receptor |
| TNFα | Tumor necrosis factor-α |
| γGT | γglutamyl-transferase |